Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00880256 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data

A NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.

Completed
Registry status
NA
Development phase
93
Enrollment target

NCT00880256 is a NA study that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 93 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00880256, a NA study, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target

Study Summary

Irritable bowel syndrome (IBS) is a very common, chronic disorder that significantly affects quality of life, and results in enormous expenditures each year in the United States. Therapy for IBS is generally unsatisfactory, and takes an additive approach whereby medications are prescribed according to each type of symptom the patient experiences. Accumulating evidence indicates that persons with IBS have a heightened perception of stress, and chronic stress has been shown to have a significant impact on IBS symptomatology. Mindfulness involves the ability to bring attention to the present moment without judgment; this ability is correlated with measures of mental health and decreased stress perception. The clinical literature suggests that mindfulness-based interventions may lead to improvement in many disorders including chronic pain, stress, anxiety, eating disorders and depressive relapse. The purpose of this study is to collect survey pilot data to determine whether an 8-week program of mindfulness-based stress reduction (MBSR) improves symptoms and quality of life for persons with IBS. Patients in the 8-week MBSR program are referred as part of their clinical care, and we seek approval only to collect survey data before and after the MBSR course. This study will evaluate whether there is sufficient evidence of efficacy to warrant a full clinical trial of MBSR.

Interventions

  • BEHAVIORAL mindfulness-based stress reduction

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2008-09
Est. Completion 2010-10
Phase NA

What the Registry Record Tells You About NCT00880256

The ClinicalTrials.gov registry entry for NCT00880256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which mindfulness-based stress reduction is the first listed.

NCT00880256 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00880256 about?

NCT00880256 is a clinical study titled "Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data". Irritable bowel syndrome (IBS) is a very common, chronic disorder that significantly affects quality of life, and results in enormous expenditures each year in the United States. Therapy for IBS is generally unsatisfactory, and takes an additive approach whereby medications are prescribed according ...

What is the current status of trial NCT00880256?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2008-09. Estimated completion is 2010-10.

What interventions are being tested in trial NCT00880256?

The interventions under investigation include: mindfulness-based stress reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT00880256?

This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.